Types of Hair Loss and Their Respective Treatment Plans

Hair loss affects approximately 85% of men and 33% of women at some point during their lifetime, yet the condition is widely misunderstood because it encompasses several clinically distinct disorders rather than a single disease. 1 Correctly identifying the type of hair loss a person is experiencing determines which treatment approaches are appropriate, how urgently intervention is needed, and whether regrowth is biologically possible. 2 This guide examines the major recognized types of hair loss, their underlying mechanisms, and the evidence-based treatment plans dermatologists employ for each.

The Scarring vs. Non-Scarring Classification Framework

Dermatologists classify all forms of alopecia into two broad categories: scarring and non-scarring. Non-scarring alopecia is the most common category and does not permanently destroy hair follicles, meaning hair loss may be temporary or reversible with appropriate treatment. 3 Scarring alopecia, by contrast, involves irreversible follicle damage. Once fibrosis is complete in a scarring form, no topical medication, injection, or laser therapy can regenerate a destroyed follicle, making early diagnosis critically important. 4 A dermatologist evaluates the location, pattern, scalp appearance, and follicle markings present in the affected area to determine which category applies before any treatment plan is formulated.

Diagnostic tools used to distinguish types include blood tests to identify underlying medical causes, pull tests to assess shedding stage, scalp biopsy to examine follicle integrity under a microscope, and light microscopy to detect hair shaft disorders. 5 This clinical process matters because two patients with visually similar hair loss patterns may require entirely different treatment protocols depending on the underlying mechanism driving follicle disruption.

Androgenetic Alopecia: Pattern Hair Loss and Its Treatment Plan

Androgenetic alopecia is the most prevalent form of hair loss, accounting for approximately 80% of all hair loss cases in men and affecting around 50% of men over age 40 and 25% of women in the same age range. 6 The condition is driven by genetic sensitivity of hair follicles to dihydrotestosterone (DHT), a byproduct of testosterone produced by the enzyme 5-alpha-reductase. DHT binds to follicle receptors and progressively shortens the anagen growth phase with each cycle until the follicle miniaturizes and stops producing visible hair. 7 In men, progression typically follows the Norwood scale from a receding hairline toward crown loss, while in women it follows the Ludwig scale with diffuse thinning over the central scalp and a preserved frontal hairline.

The treatment plan for androgenetic alopecia centers on two FDA-approved medications with decades of controlled trial data: topical minoxidil, approved in 1988, and oral finasteride, approved in 1997 and indicated for men only. 8 Finasteride at 1 mg daily reduces scalp DHT by approximately 60%, slowing miniaturization measurably. Minoxidil extends the anagen phase and improves follicle blood supply and is available in liquid, foam, and shampoo formulations. Results from either medication typically become visible after three to six months of consistent use, and discontinuation leads to resumption of loss within six to twelve months. 9 For advanced stages, follicular unit extraction (FUE) hair transplantation achieves graft survival rates exceeding 90% and represents the only permanent restoration option. 10 Platelet-rich plasma (PRP) and low-level laser therapy (LLLT) serve as adjunct options that support density improvement but do not replace first-line pharmacological therapy.

Alopecia Areata: Autoimmune Patchy Hair Loss and Its Treatment Plan

Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles, producing smooth, well-defined round patches of hair loss that can appear suddenly. An estimated 7 million people in the United States will experience this condition during their lifetime, representing approximately 1 to 2 percent of the population. 11 The condition can affect the scalp, eyebrows, eyelashes, beard area, and body hair. In severe variants, alopecia totalis involves complete scalp hair loss, while alopecia universalis involves loss of all body hair. Because follicles are not permanently destroyed in most cases, regrowth remains biologically possible.

Treatment plans for alopecia areata are stratified by severity. For mild cases, topical corticosteroids serve as the first-line approach by reducing inflammation around follicles and potentially stimulating regrowth. Intralesional corticosteroid injections are effective for mild to moderate cases, with initial results typically observable within six to eight weeks. 12 For moderate to severe or rapidly progressing disease, JAK inhibitors have emerged as a breakthrough treatment category. Baricitinib received FDA approval for severe alopecia areata in 2022, representing the first systemic approval specifically for this condition in decades. 13 Immunotherapy approaches using topical sensitizers such as diphenylcyclopropenone (DPCP) are also used in specialist settings for extensive or treatment-resistant cases.

Telogen Effluvium and Anagen Effluvium: Stress- and Treatment-Triggered Shedding

Telogen effluvium is a non-scarring, diffuse shedding disorder caused by a disruption to the hair growth cycle that pushes a large number of follicles prematurely into the telogen resting phase. Shedding typically becomes noticeable two to three months after the triggering event, which may include significant physical illness, surgery, childbirth, rapid weight loss, major psychological stress, or nutritional deficiency. 14 The condition generally resolves without specific treatment within six to twelve months once the underlying trigger is corrected, though short-term minoxidil may be used to support cycle normalization during recovery. Nutritional deficiencies in iron, zinc, biotin, vitamin D, and protein are documented contributors to diffuse shedding and are addressed through targeted dietary supplementation. 15

Anagen effluvium is a distinct but related condition involving rapid, diffuse hair loss caused by damage to actively growing follicles, most commonly from chemotherapy or radiation therapy. Unlike telogen effluvium, which unfolds over months, anagen effluvium can produce visible loss within days to weeks of treatment initiation. 16 Hair typically begins to regrow three to six months after the causative treatment is completed. The scalp cooling technique, used during certain chemotherapy regimens, has clinical evidence supporting reduction in anagen effluvium severity, though its applicability depends on the specific drug regimen and oncology protocol.

Traction Alopecia and Scarring Alopecia: Mechanical and Destructive Forms

Traction alopecia is a non-scarring form caused by chronic mechanical tension applied to the hair follicle, typically from tight hairstyles such as braids, weaves, extensions, or high ponytails. Hair loss initially presents along the hairline and temples and is reversible if the source of tension is removed early. 17 If traction is sustained over a prolonged period, follicle damage can progress from reversible to permanent, transitioning the condition into a scarring category. The primary treatment plan is elimination of the offending hairstyle combined with gentle scalp care and, if inflammation is present, short-course topical or intralesional corticosteroids. Early recognition by a dermatologist is essential to prevent irreversible progression.

Scarring alopecias, also called cicatricial alopecias, encompass a group of disorders including lichen planopilaris, frontal fibrosing alopecia, discoid lupus erythematosus, and folliculitis decalvans. These conditions share the mechanism of inflammatory destruction of follicle stem cells followed by replacement with fibrous scar tissue. 18 Treatment goals shift from regrowth to halting progression, as destroyed follicles cannot be regenerated. Dermatologist-guided immunosuppressive therapy using corticosteroids, hydroxychloroquine, retinoids, or antibiotics forms the core of management, with the specific protocol depending on the subtype of scarring alopecia identified. 4 Hair transplantation may be considered for cosmetic restoration in stable, inactive scarring alopecia, but only after disease activity has been confirmed as quiescent.

Additional Types: Trichotillomania, Fungal, and Behavioral Causes

Trichotillomania is a body-focused repetitive behavior disorder in which individuals repeatedly pull out their own hair, resulting in irregular patches of loss that differ in shape and texture from autoimmune or genetic causes. Unlike other forms of alopecia, the primary treatment is psychological rather than dermatological. Cognitive behavioral therapy and habit reversal training are established first-line interventions, and pharmacological support using SSRIs or N-acetylcysteine supplements may be incorporated for eligible patients. 19 Tinea capitis, a fungal infection of the scalp caused by dermatophytes, produces inflammatory hair loss particularly in children and is treated with systemic antifungal agents such as terbinafine or griseofulvin, as topical agents alone do not reach the follicle depth required for resolution. 20

Across all these types, the consistent evidence-based recommendation is that early assessment improves outcomes. Patients who plan treatment comprehensively in the early stages of loss report higher satisfaction rates than those who delay, and the biological window for reversing follicle miniaturization in conditions like androgenetic alopecia narrows meaningfully with time. 21 A board-certified dermatologist remains the appropriate specialist for confirming diagnosis, ruling out systemic causes, and constructing an individualized, evidence-supported treatment plan for any form of hair loss.

Treatment Plan Comparison by Hair Loss Type

Sources

1. Healthline - Most Effective Hair Loss Treatments In 2026, According to Experts: https://www.healthline.com/health-news/best-hair-loss-treatments-2026-experts
2. HairClub - Types of Hair Loss: What's Behind It and What Can Help: https://www.hairclub.com/blog/types-of-hair-loss-whats-behind-it-and-what-can-help/
3. Penn Medicine - Hair Loss (Alopecia) Symptoms and Causes: https://www.pennmedicine.org/conditions/hair-loss-alopecia
4. DermNet NZ - Cicatricial Alopecia: https://dermnetnz.org/topics/cicatricial-alopecia
5. Mayo Clinic - Hair Loss Diagnosis and Treatment: https://www.mayoclinic.org/diseases-conditions/hair-loss/diagnosis-treatment/drc-20372932
6. ALMO Clinic - Types of Alopecia: Differences, Causes and Treatment for Each: https://www.almoclinic.com/en/blog/types-of-alopecia/
7. Keit.al - Androgenetic Alopecia Causes, Signs and Treatments: https://www.keit.al/en/androgenetic-alopecia-causes-signs-treatments/
8. Top Doctor Magazine - Hair Loss Treatment Options Doctor Guide 2026: https://topdoctormagazine.com/doctor/hair-loss-treatment-options-doctor-guide/
9. Assure Clinic - Best Hair Loss Treatments in 2026 Ranked: https://assureclinic.com/blog/best-hair-loss-treatments-ranked/
10. International Society of Hair Restoration Surgery - Hair Restoration Surgery Guide: https://www.ishrs.org/hair-restoration-surgery-guide
11. National Institute of Arthritis and Musculoskeletal and Skin Diseases - Alopecia Areata: https://www.niams.nih.gov/health-topics/alopecia-areata
12. Doctronic - Comprehensive Guide to Alopecia Areata Treatment Options: https://www.doctronic.ai/blog/alopecia-areata-treatment/
13. Charles Medical Group - Hair Loss Treatment in 2026 Evidence-Based Decision Framework: https://charlesmedicalgroup.com/general/hair-loss-treatment-2026-framework/
14. American Academy of Dermatology - Telogen Effluvium: https://www.aad.org/public/diseases/hair-loss/types/telogen-effluvium
15. Dermatology Practical and Conceptual - Nutritional Deficiencies and Hair Loss: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380979/
16. Cancer.net - Hair Loss (Alopecia) from Chemotherapy: https://www.cancer.net/navigating-cancer-care/side-effects/hair-loss-alopecia
17. American Academy of Dermatology - Traction Alopecia: https://www.aad.org/public/diseases/hair-loss/types/traction
18. Acibadem International - Alopecia Treatment How Different Types Are Managed: https://acibademinternational.com/health-library/alopecia-treatment-how-different-types-are-managed/
19. Cleveland Clinic - Trichotillomania Hair Pulling Disorder: https://my.clevelandclinic.org/health/diseases/9888-trichotillomania-hair-pulling-disorder
20. American Family Physician - Tinea Capitis Treatment: https://www.aafp.org/pubs/afp/issues/2003/0515/p2101.html
21. MyHairline.ai - Hair Loss Treatment Hierarchy Guide Chapter 1: https://www.myhairline.ai/blog/hair-loss-treatment-hierarchy-ch1-understanding-hair-loss